We are live on ! Find out more
TXMD icon

TherapeuticsMD

44 hedge funds and large institutions have $7.73M invested in TherapeuticsMD in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

551% more capital inflows, than outflows

Capital inflows: $342K | Capital outflows: $52.6K

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

100% more call options, than puts

Call options by funds: $32K | Put options by funds: $16K

13% more funds holding

Funds holding: 39 → 44 (+5)

1.18% more ownership

Funds ownership: 30.74% → 31.92% (+1.2%)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
44
Holders Change
+5
Holders Change %
+12.82%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
8
Closed
4
Calls
$32​K
Puts
$16​K
Net Calls
+$16​K
Net Calls Change
-⁠$24​K

TXMD Hedge Fund Activity: Q1 2024 in Review

44 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2024, worth a combined $7.73M — up 5.7% from $7.32M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TXMD positions and 4 closed out — a net gain of 5 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was Clearline Capital, adding an estimated $160K. The largest seller was Gabelli Funds, cutting an estimated $39.4K.

  • 44 institutional investors held TherapeuticsMD (TXMD) as of Q1 2024, up from 39 in Q4 2023.
  • Funds reported $7.73M of TherapeuticsMD stock for Q1 2024, up 5.7% quarter-over-quarter.
  • 9 funds opened new TherapeuticsMD positions in Q1 2024 and 4 closed out, a net change of +5 holders.
  • The largest TherapeuticsMD buyer in Q1 2024 was Clearline Capital, an estimated $160K added.
  • The largest TherapeuticsMD seller in Q1 2024 was Gabelli Funds, an estimated $39.4K sold.

Based on aggregated 13F filings for Q1 2024.